Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 102 results found. Search for [ COVID-19 vaccine emergency use China ]

Results 1 to 21 of 102
BusinessToday.In
January 27, 2021
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation


Rashi Bisaria
New Delhi, January 18, 2021
COVID-19 vaccination Day 2: 2.25 lakh inoculated; 447 adverse events reported A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the Union Health Ministry said on day two of the nationwide vaccination drive on Sunday. Out of the 447 adverse events following immunisation, only three required hospitalisation. India has approved two vaccines -- Covaxin developed by Bharat Biotech...


Reuters
January 17, 2021
COVID-19 vaccine: Pakistan, which is seeing rising numbers of coronavirus infections, said its vaccines would be procured from multiple sources


Joe C Mathew | Nidhi Singal
January 14, 2021
Key to the success of the pan-India COVID-19 vaccination drive, scheduled to be launched by PM Narendra Modi on January 16, will be the cybersecurity framework India has readied, experts say


BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine


Anup Jayaram
January 11, 2021
As the world marches towards immunity, a bigger problem is the emergence of new strains of the virus, some more deadly and infectious than the original, warns WHO Chief Scientist Dr. Soumya Swaminathan


Rajeev Dubey | Vivek Punj
January 11, 2021
Full authorisation-better known as \"full pre-qualification\"-is a pre-requisite to sell the vaccine in the open market or for mass immunisation of healthy individuals who are not frontline workers


BusinessToday.In
January 9, 2021
Critics have said that the country's immunisation campaign is running behind its regional peers and have questioned why the government has not moved more swiftly


BusinessToday.In
January 8, 2021
Bharat Biotech chairman Krishna Ella says this nasal vaccine will revolutionise Indian vaccine making capabilities and help it leapfrog along with Europe, the US and China


Rashi Bisaria
New Delhi, January 7, 2021
US, UK warn Moderna, Pfizer vaccine may cause fever, weak immunity Debates continue in India whether the two COVID-19 vaccines that got emergency use authorisation from the country's drug regulator recently are safe and efficacious. The fact sheets for vaccine recipients in US and UK for Moderna and Pfizer-BioNTech vaccines say the vaccines are yet to be fully approved. Moderna's fact sheet for recipients says its vaccine is unapproved and 'may prevent COVID-19'. The UK government says it h...


BusinessToday.In
January 4, 2021
In line with positive global equities, Sensex ended 307 points higher at 48,176 and Nifty gained 114 points to 14,132. During today's session, Sensex hit a lifetime high of 48,220 and Nifty rose to a new high of 14,147


BusinessToday.In
January 4, 2021
Coronavirus vaccine: China has not done any efficacy trials, Russia also has not done any efficacy trials. We are doing efficacy trials on 26,000 people in the third phase, he said


BusinessToday.In
January 4, 2021
The Prime Minister said this while virtually addressing the crowd at the inauguration of National Atomic Timescale and Bhartiya Nirdeshak Dravya at the National Metrology Conclave


BusinessToday.In
January 4, 2021
TCS, ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank were among the gainers. On the other hand, HDFC, Asian Paints and Reliance Industries were among the laggards


Reuters
January 3, 2021
India on Sunday granted emergency approval to Bharat Biotech's COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine


PTI
January 3, 2021
A study suggests that chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19


BusinessToday.In
January 1, 2021
Reports suggest that an expert panel will meet to take up the application for emergency use of the three vaccines


Reuters
January 1, 2021
The variant was detected in a 23-year-old female student returning to China from Britain, who was tested in Shanghai on December 14


Rupa Burman Roy
December 31, 2020
ONGC, Airtel, RIl, Titan, Maruti, ICICI Bank, HDFC and Bajaj Finserve were among the top gainers. On the other hand, TCS, Infosys, M&M, Ultratech Cement, HUL, NTPC and SBI were among the top losers today


PAGES 1 OF 6  12345